Enrollment has been completed for a phase 2a randomized clinical trial evaluating the investigational microbiome therapeutic EBX-102-02 in patients undergoing allogeneic hematopoietic stem cell ...

Sepsis and severe pneumonia are frequently accompanied by disruption of the gut microbiota, leading to immune dysfunction and ...

Short-term antibiotics reshape the gut microbiome and reduce neuroinflammation after traumatic brain injury in mice. Learn ...

Restoring the gut microbiota through fecal microbiota transplantation reversed these effects. The treatment replenished CX3CR1-positive NK cells, reduced lung damage, and improved survival. Targeted ...

EnteroBiotix has completed enrolment in a Phase 2a trial of EBX 102 02, a microbiome therapy given before allogeneic stem cell transplantation. The study will evaluate whether restoring gut microbial ...

Researchers discovered that clearing out certain digestive bacteria with antibiotics helps calm the immune system. This temporary microbial shift protected mice from severe brain swelling and cellular ...

Gut microbiota may shape liver metastasis in small cell lung cancer and influence treatment response. Read more.

EnteroBiotix, a clinical-stage biopharmaceutical company developing best-in-class microbiome therapies, today announced that the investigator-initiated Phase 2a MAST trial (Intestinal Microbiota ...

This schematic illustrates the synthesis, screening, and antibacterial mechanism of amine-modified carbon dots derived from corn straw biomass. Among the materials tested, TETA-modified carbon dots ...